RDY Adds to Generic Portfolio - Updated
News | 21 May 2012
Dr. Reddy's Laboratories (RDY - Snapshot Report) has been busy launching generics and the recent US launch of a generic version of Novatis AG's (NVS - Snapshot Report) over-the-counter (OTC) drug, Prevacid, was the second one in less than a week.
Click on the link to read the full article at The Mumbai Times
(This link will open in a new window)
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
